Alzheimer's disease

Data from a third long-term study, ADAPT (The Alzheimer's Disease Anti-inflammatory Prevention Trial), did not show a significantly increased cardiovascular risk with celecoxib 200mg BID compared to placebo.
Los resultados de un tercer estudio a largo plazo, ADAPT (Estudio de Prevención Antiinflamtoria de la Enfermedad de Alzheimer) no demostraron ningún incremento significativo del riesgo cardiovascular con celecoxib 200 mg dos veces al día en comparación con placebo.
Other Dictionaries
Explore the meaning of Alzheimer's disease in our family of products.
Word of the Day
scarecrow